Evidence map›Paper›PMID 41278948›Full record

ArticlebioRxiv : the preprint server for biology2025

Elevation of the mechanically-sensitive protein emerin links nuclear mechanotransduction to tau-induced cytoskeletal remodeling in neurons.

Claira Sohn, Sammy Pardo, Dana Molleur, Satvik R Paduri, Morgan Lambert, Morgan G Thomas, Erich J Sohn, Susan T Weintraub, Bess Frost

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Claira SohnDepartment of Cell Systems and Anatomy, Barshop Institute for Longevity and Aging Studies, Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University of Texas Health San Antonio, San Antonio, Texas, United States.
Sammy PardoDepartment of Biochemistry and Structural Biology, University of Texas Health San Antonio, San Antonio, Texas, United States.
Dana MolleurDepartment of Biochemistry and Structural Biology, University of Texas Health San Antonio, San Antonio, Texas, United States.
Satvik R PaduriDepartment of Molecular Biology, Cell Biology and Biochemistry, Center for Alzheimer's Disease Research, Brown University, Providence, Rhode Island, United States.
Morgan LambertDepartment of Molecular Biology, Cell Biology and Biochemistry, Center for Alzheimer's Disease Research, Brown University, Providence, Rhode Island, United States.
Morgan G ThomasDepartment of Molecular Biology, Cell Biology and Biochemistry, Center for Alzheimer's Disease Research, Brown University, Providence, Rhode Island, United States.
Erich J SohnDepartment of Biochemistry and Structural Biology, University of Texas Health San Antonio, San Antonio, Texas, United States.
Susan T WeintraubDepartment of Biochemistry and Structural Biology, University of Texas Health San Antonio, San Antonio, Texas, United States.
Bess FrostDepartment of Molecular Biology, Cell Biology and Biochemistry, Center for Alzheimer's Disease Research, Brown University, Providence, Rhode Island, United States.ORCID 0000-0002-1212-8138

Funding

Mechanisms of tau- and aging-induced neurological dysfunction: Focus on the nucleusR01AG057896 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI FROST, BESS · 2019 to 2023
$2.8M
Investigating mechanisms of neuronal nuclear mechanotransduction in physiological conditions and tauopathyF31NS137774 · NINDS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI SOHN, CLAIRA ROSE · 2024 to 2025
$78k
NIA NIH HHS R01 AG057896NINDS NIH HHS F31 NS137774
6 · The paper itself

Abstract

Tauopathies are a group of neurodegenerative disorders, including Alzheimer's disease, that are neuropathologically defined by deposition of pathological forms of tau in the brain. While tau is reported to drive neurotoxicity by negatively affecting cytoskeletal, nucleoskeletal, and genomic architecture, the mechanisms mediating tau-induced dysfunction of the cytoskeleton and nucleoskeleton are incompletely understood. Based on proteomic profiling, we identify a suite of cytoskeletal and nucleoskeletal proteins with differing abundance in a cellular model of tauopathy, iTau. Building upon previous findings that pathogenic forms of tau reduce nuclear tension, we find that protein levels of emerin, a central regulator of nuclear mechanotransduction, are significantly elevated in iTau cells and in induced pluripotent stem cell (iPSC)-derived neurons carrying a mutation in the microtubule-associated protein tau (

Indexed as

Alzheimer’s diseasecytoskeletonemerinmechanotransductionnucleustautauopathy

Identifiers

PMID41278948
PMCPMC12633049

What OpenQuestion holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.